A study on prescription patterns, adverse drug reactions and medication awareness in Schizophrenia patients
- Conditions
- Health Condition 1: null- Schizophrenia patients diagnosed as per DSM-V criteria and their caregiversHealth Condition 2: F209- Schizophrenia, unspecified
- Registration Number
- CTRI/2018/03/012533
- Lead Sponsor
- Seth GS Medcial College and KEM Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 250
Inclusion Criteria for patients:
1. Male or female patients with age 18-65 years, attending Psychiatry OPD for existing Schizophrenia diagnosed as per DSM-V Criteria
2. Patients carrying treatment records prescribed at Psychiatry OPD of KEM Hospital, containing antipsychotic medication regimen for at least 3 months
3. For patients who will be given the drug awareness questionnaire, insight score equal to or above 9 on Birchwood insight scale thereby suggesting that patient has good insight
Inclusion criteria for the caregivers:
1.Primary caregivers of the patient.
2. Those who give written informed consent
Exclusion Criteria for patients:
1.Patients admitted to psychiatry IPD and emergency department as well as referred patients
2. Newly diagnosed and treatment-naive patients
3.Patients with a history of Substance dependence or abuse at the current visit.
4.Patients with other Neurological disorders (dementia, delirium, and other cognitive disorders), seizure disorders, with sensory impairment and other psychiatric disorders such as mood disorders, and anxiety disorders.
5.Critically ill patients requiring urgent attention to medical problems
Exclusion criteria for the caregivers:
1. Those with age < 18 years and > 65 years
2. Those having neurological disorders such as dementia, delirium and other cognitive disorders
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To study the awareness of drug treatment in Schizophrenic patients having insightTimepoint: Single point (cross sectional study), 18 months duration
- Secondary Outcome Measures
Name Time Method To study the awareness of drug treatment in Schizophrenic patients having insightTimepoint: Single point (cross sectional study), 18 months duration